Sort
130,381 grants matching “hiv”
CMOS-Integrated Fluorescence Biochip SBIR Phase II Grant Application
$810,812Arjang Hassibi · Insilixa, Inc. · R44 · FY2015 · HG
Preclinical modeling to study Tuberculous Meningitis
$810,795Sanjay Jain · Johns Hopkins University · R01 · FY2021 · AI
Modeling the Impact of HIV Prevention Interventions
$810,786George R Seage · Harvard School Of Public Health · R01 · FY2010 · MH
Demystifying the antiviral activity of the IgG3+ antibody response
$810,753Galit Alter · Massachusetts General Hospital · R37 · FY2018 · AI
Core 3
$810,666Yifan Cheng · University Of California, San Francisco · U54 · FY2022 · AI
STRUCTURES OF HIV REVERSE TRANSCRIPTASE WITH SUBSTRATES
$810,658Rutgers The St Univ Of Nj New Brunswick · R37 · FY2004 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$810,615Krishna P Reddy · Massachusetts General Hospital · R01 · FY2022 · AI
HIV Risk Dynamics, Genetic Patterns, and Control
$810,590James Stephen Koopman · University Of Michigan At Ann Arbor · R01 · FY2011 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,532Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,532Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,531Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,531Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,531Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children
$810,525Lisa M Bebell · Massachusetts General Hospital · R01 · FY2023 · HD
Video DOT and Economic Incentives to promote adherence to LTBI therapy
$810,520Maunank Shah · Johns Hopkins University · R01 · FY2025 · AI
Studies of Rare Cancers
$810,495Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
$810,475Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Risk, Roles and Relationships: Project Prepared
$810,441Laurie J Bauman · Albert Einstein College Of Medicine · R01 · FY2009 · HD
Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodes
$810,339Steven A Yukl · Northern California Institute/Res/Edu · R01 · FY2021 · DK
Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodes
$810,339Steven A Yukl · Northern California Institute/Res/Edu · R01 · FY2022 · DK
Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodes
$810,339Steven A Yukl · Northern California Institute/Res/Edu · R01 · FY2020 · DK
Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodes
$810,339Steven A Yukl · Northern California Institute/Res/Edu · R01 · FY2023 · DK
Center for Metabolic Research on HIV and Drug Use
$810,288Sherwood L Gorbach · Tufts University Boston · P30 · FY2010 · DA
Immune engineering of optimized sequential immunization strategies for HIV vaccines
$810,280Darrell J Irvine · Massachusetts Institute Of Technology · R33 · FY2024 · AI
Therapeutic DNA/MVA Vaccines for HIV
$810,264Rama Rao Amara · Emory University · R01 · FY2007 · AI